Tech Company Financing Transactions

MBX Biosciences Funding Round

Frazier Healthcare Partners, BioCrossroads and IU Health Ventures joined a $34.6 million Series A venture round for MBX Biosciences. The round closed on 7/29/2020.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

11711 N. Meridian St. 310
Carmel, IN 46032
USA

Phone

Undisclosed

Website

www.mbxbio.com

Email Address

[email protected]

Overview

MBX Biosciences is a preclinical-stage biotech company committed to creating therapies to treat rare endocrine diseases where there is inadequate treatment available. MBX's leadership team has collaborated successfully over several decades to discover, develop and commercialize first-in-class endocrine therapeutics.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Kent Hawryluk

        

Chief Operating Officer

Timothy Knickerbocker

        

Chief Scientific Officer

Richard DiMarchi

        

VP - Finance

Lisa Redman

        

VP - Product Management

Gregory Davis

        

Browse more venture capital transactions:

Prev: 7/29/2020: Conexiom venture capital transaction
Next: 7/29/2020: boostr venture capital transaction

Share this article

News on VC Transactions

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary